NEUROPATHIX, INC. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3e3e786c-095f-4603-bf8c-57bf007acf33/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-3.6M | 2021-01-01 – 2021-12-31 | evidence 0001607062-22-000284 |
| FY 2020 | $-4.5M | 2020-01-01 – 2020-12-31 | evidence 0001607062-21-000063 |
| FY 2019 | $-3.5M | 2019-01-01 – 2019-12-31 | evidence 0001607062-20-000083 |
| FY 2018 | $931.1k | 2018-01-01 – 2018-12-31 | evidence 0001607062-20-000083 |
| FY 2017 | $-1.6M | 2017-01-01 – 2017-12-31 | evidence 0001078782-19-000306 |
| FY 2016 | $-32.0k | 2016-01-01 – 2016-12-31 | evidence 0001615999-17-000003 |
| FY 2015 | $4.7k | 2015-01-01 – 2015-12-31 | evidence 0001615999-17-000003 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).